Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 410 | 344 | 707 | 1,376 | 223 |
| Receivables | 9,091 | 8,739 | 8,240 | 11,066 | 10,457 |
| Inventories | 4,101 | 4,455 | 4,623 | 4,386 | 4,796 |
| Other current assets | 1,442 | 1,389 | 1,415 | 1,430 | 1,581 |
| TOTAL | $15,044 | $14,927 | $14,985 | $18,258 | $17,057 |
| Non-Current Assets | |||||
| PPE Net | 2,346 | 2,401 | 2,623 | 2,893 | 3,708 |
| Investments And Advances | N/A | N/A | N/A | 0 | 4,987 |
| Intangibles | 18,024 | 18,297 | 18,697 | 18,742 | 20,739 |
| Other Non-Current Assets | 1,692 | 1,944 | 2,226 | 2,478 | 3,075 |
| TOTAL | $22,062 | $22,642 | $23,546 | $24,113 | $32,509 |
| Total Assets | $37,106 | $37,569 | $38,531 | $42,371 | $49,566 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,440 | 9,877 | 9,306 | 6,015 | 4,256 |
| Accounts payable and accrued liabilities | 4,541 | 5,159 | 5,983 | 5,826 | N/A |
| Other current liabilities | 173 | 234 | 261 | 299 | 380 |
| TOTAL | $17,531 | $17,255 | $17,523 | $14,377 | $13,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,531 | 5,957 | 4,719 | 10,142 | 11,009 |
| Deferred Revenues | 1,444 | 1,031 | 908 | 1,193 | 1,253 |
| Other Non-Current Liabilities | 153 | 149 | 157 | 158 | 167 |
| TOTAL | $8,319 | $7,673 | $6,777 | $12,448 | $13,906 |
| Total Liabilities | $25,850 | $24,928 | $24,300 | $26,825 | $27,006 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,824 | N/A | N/A | N/A | N/A |
| Common Shares | 57,954 | 57,954 | 57,565 | 57,565 | 57,538 |
| Retained earnings | -53,531 | -52,031 | -49,909 | -48,602 | -41,150 |
| Other shareholders' equity | 461 | 416 | 445 | 584 | 372 |
| TOTAL | $11,256 | $12,641 | $14,231 | $15,546 | $22,560 |
| Total Liabilities And Equity | $37,106 | $37,569 | $38,531 | $42,371 | $49,566 |